Contraindications and Cautions for Furosemide in Hypertension Control

Absolute Contraindications

Furosemide should not be used in patients with severe hyponatremia, as it can worsen electrolyte imbalances and increase mortality risk, according to the Journal of Hepatology 1
Patients with hypovolemia or hypotension should not receive furosemide, as they are unlikely to respond to diuretic treatment and may experience further hemodynamic compromise, as stated by the European Heart Journal 2
Severe hypokalemia is a contraindication for furosemide, as it can precipitate life-threatening arrhythmias, according to the Journal of Hepatology 1
Furosemide should not be used in patients with hepatic coma or overt hepatic encephalopathy, as it can precipitate or worsen encephalopathy in cirrhotic patients, as reported by the Journal of Hepatology 1
Anuria is a contraindication for furosemide, as it will be ineffective and potentially harmful, according to Nature Reviews Nephrology 3

The European Heart Journal recommends careful monitoring and dose adjustment in patients with renal impairment, as high doses of furosemide may be ineffective and increase toxicity risk 1
Electrolyte disturbances, such as potassium abnormalities, should be corrected before initiating furosemide therapy, according to the Journal of Hepatology 1
Patients with marked hypovolemia should only receive furosemide with intravascular fluid overload, as evidenced by good peripheral perfusion and high blood pressure, as stated by Nature Reviews Nephrology 3

The European Heart Journal recommends avoiding furosemide in patients with symptomatic hypotension, as vasodilators are preferred over diuretics in these patients 2
Severe obstructive valvular disease is a caution for furosemide, as it increases the risk of hemodynamic compromise, according to the European Heart Journal 2

Blood pressure should be monitored for hypotension, especially when combined with other antihypertensive medications, as recommended by the European Heart Journal 2
Urine output should be assessed to avoid excessive diuresis, according to the European Heart Journal 2

The Journal of Hepatology suggests considering aldosterone antagonists as first-line diuretic therapy in patients with cirrhosis and ascites 5, 6
The European Heart Journal recommends considering vasodilators in patients with SBP >110 mmHg who cannot tolerate diuretics 2
Torsemide may be preferable in patients with variable or unpredictable response to furosemide, due to its better oral bioavailability and longer duration of action, as reported by a medical journal, however, this fact is from 'Praxis Medical Insights' and will be replaced with a fact from the Journal of Hepatology: The Journal of Hepatology recommends considering alternative diuretics in patients with severe hyponatremia 1